Exclusion of any component from the cocktail of immunomodulatory ligands resulted in decreases in tumor cell killing efficiency, while the inclusion of CTLA-4 had no additional effects, suggesting that the combination of αCD3, αCD137, αPD-1, and IL-2 worked in complementarity with non-overlapping functions. This evidence concerns the gene IL2 and neoplasm.